Similarly, in ESCC patients, with the down-regulation of CD16 and increased expression of CD56, the NK cell levels were also declined in the tumors and exhibited an exhausted phenotype (23, 24), demonstrating the vital roles of the suppressive microenvironment formed by cancer cells in altering NK cell phenotype and activity (Figure 1). This evidence concerns the gene NCAM1 and cancer.